Akso Health Group/$AHG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Akso Health Group
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
Ticker
$AHG
Sector
Primary listing
Employees
27
Headquarters
Website
AHG Metrics
BasicAdvanced
$1B
-
-$0.48
-0.66
-
Price and volume
Market cap
$1B
Beta
-0.66
52-week high
$2.10
52-week low
$0.83
Average daily volume
12K
Financial strength
Current ratio
14.199
Quick ratio
12.827
Long term debt to equity
0.021
Total debt to equity
1.045
Profitability
EBITDA (TTM)
-1.773
Gross margin (TTM)
-1.91%
Net profit margin (TTM)
-913.38%
Operating margin (TTM)
-26.55%
Effective tax rate (TTM)
18.52%
Revenue per employee (TTM)
$550,000
Management effectiveness
Return on assets (TTM)
-1.37%
Return on equity (TTM)
-80.26%
Valuation
Price to revenue (TTM)
35.305
Price to book
5.07
Price to tangible book (TTM)
5.6
Price to free cash flow (TTM)
510.176
Free cash flow yield (TTM)
0.20%
Free cash flow per share (TTM)
0.004
Growth
Revenue change (TTM)
512.08%
Earnings per share change (TTM)
119.70%
3-year revenue growth (CAGR)
35.05%
10-year revenue growth (CAGR)
12.27%
3-year earnings per share growth (CAGR)
-17.40%
10-year earnings per share growth (CAGR)
34.40%
Bulls say / Bears say
Total revenues surged 512% to $14.78 million in fiscal 2025 from $2.42 million in fiscal 2024, driven by its new marketing promotion services segment which generated $14.37 million, demonstrating strong market adoption.
For the half‐year ended September 30, 2024, net loss narrowed to $0.587 million from $3.46 million a year earlier, reflecting improved cost control and operational leverage during the transition.
Cash and cash equivalents jumped to $176.2 million as of March 31, 2025, up from $85.2 million a year earlier, providing ample liquidity to fund growth initiatives and sustain operations.
Medical device revenue collapsed 83% year-over-year to just $415,020 in fiscal 2025, highlighting sharp demand erosion in its legacy core business.
Its primary revenue segment—marketing promotion services—operated at a negative 1.9% gross margin in fiscal 2025, indicating the company is currently losing money on its main growth engine.
The company recorded a $135.5 million net loss in fiscal 2025, a nearly 1,300% increase from $9.5 million in fiscal 2024, far outstripping its modest revenue base and raising sustainability concerns.
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Akso Health Group stock?
Akso Health Group (AHG) has a market cap of $1B as of September 15, 2025.
What is the P/E ratio for Akso Health Group stock?
The price to earnings (P/E) ratio for Akso Health Group (AHG) stock is 0 as of September 15, 2025.
Does Akso Health Group stock pay dividends?
No, Akso Health Group (AHG) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Akso Health Group dividend payment date?
Akso Health Group (AHG) stock does not pay dividends to its shareholders.
What is the beta indicator for Akso Health Group?
Akso Health Group (AHG) has a beta rating of -0.66. This means that it has an inverse relation to market volatility.